skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Reaching more senior decision makers than ever before!

Outlook 2020 is the annual look at the performance and future prospects of the global pharmaceutical industry. This year, the supplement will reach more people than ever before with distribution to In Vivo, Pink Sheet, Scrip, Medtech Insight and Generics bulletin subscribers PLUS events such as Biotech Showcase and Partnerships in Clinical Trials.

The supplement comprises a league table of pharma’s top 100 performers, as well as features analyzing the outlook for the biopharma and medtech industries in 2020. This data and
analysis informs our readers’ commercial strategy and their competitor knowledge base. Framing this data are chapters that provide intelligence and insight into the most pressing challenges the industry faces in the upcoming year. This year’s editorial explores innovation in R&D, manufacturing challenges, digital and AI, as well as market and patient access issues; alongside exclusive interviews with C-suite executives and analysis of the annual industry league tables.


  • $name, $name, Scrip: 世界の医療用医薬品&製薬産業に関するニュース

    Scrip Asia 100: Sponsorship Opportunities

    The annual “Scrip Asia 100”, the highly anticipated financial performance ranking of pharma companies headquartered in the APAC region, is coming soon. Don’t miss your opportunity to position yourself as a leader in APAC pharma with a sponsorship in this indispensable publication.  

    Topics Company Analysis $name $name